Source-grounded facts extracted from Greenwich LifeSciences, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Greenwich LifeSciences, Inc. engaged MaloneBailey LLP as its auditor.
“On July 19, 2025, the audit committee of the Board of Directors of Greenwich LifeSciences, Inc. (the "Company") approved the dismissal of RBSM LLP ("RBSM") as the Company's independent registered public accounting firm and approved the engagement of MaloneBailey LLP ("MaloneBailey") as the Company's independent registered public accounting firm”
Auditor Changes
Greenwich LifeSciences, Inc. dismissed RBSM LLP as its auditor.
“On July 19, 2025, the audit committee of the Board of Directors of Greenwich LifeSciences, Inc. (the "Company") approved the dismissal of RBSM LLP ("RBSM") as the Company's independent registered public accounting firm”
Auditor Changes
Greenwich LifeSciences, Inc. engaged RBSM LLP as its auditor.
“approved the engagement of RBSM LLP (“RBSM”) as the Company’s independent registered public accounting firm to audit the Company’s consolidated financial statements for the year ended December 31, 2023”
Auditor Changes
Greenwich LifeSciences, Inc. dismissed MaloneBailey LLP as its auditor.
“On February 14, 2024, the audit committee of the Board of Directors of Greenwich LifeSciences, Inc. (the “Company”) approved the dismissal of MaloneBailey LLP (“Malone”) as the Company’s independent registered public accounting firm”
Shareholder Votes
Greenwich LifeSciences, Inc. shareholders approved Ratification of the appointment of Malone Bailey, LLP as the independent registered public accounting firm for the fiscal year ended December 31, 2023. at the 2023-12-15 meeting.
“Proposal 2. The appointment of Malone Bailey, LLP as the Company’s independent registered public accounting firm for its fiscal year ended December 31, 2023 was ratified and approved by the stockholders by the votes set forth in the table below: For Against Abstain Broker Non Vote 8,210,833 14,108 7,449 1”
Shareholder Votes
Greenwich LifeSciences, Inc. shareholders approved Election of five (5) nominees for director to serve until the 2024 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, or until such director’s earlier resignation, removal or death. at the 2023-12-15 meeting.
“Proposal 1 . All of the five (5) nominees for director were elected to serve until the 2024 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, or until such director’s earlier resignation, removal or death. The result of the votes to elect the five (5) directors was as follows: Directors For Against Abstain Broker Non Vote David McWilliams 7,005,454 0 308,802 918,135 Snehal S. Patel 7,140,753 0 173,503 918,135 Eric Rothe 7,034,141 0 280,115 918,135 F. Joseph Daugherty, M.D. 7,139,876 0 174,381 918,134 Kenneth Hallock 7,080,646 0 233,610 918,135”
Shareholder Votes
Greenwich LifeSciences, Inc. shareholders approved Ratification of Malone Bailey, LLP as independent registered public accounting firm for fiscal year 2022 at the 2022-12-09 meeting.
“Proposal 2. The appointment of Malone Bailey, LLP as the Company’s independent registered public accounting firm for its fiscal year ended December 31, 2022 was ratified and approved by the stockholders by the votes set forth in the table below: For Against Abstain Broker Non Vote 9,733,708 15,043 6,444 0”
Shareholder Votes
Greenwich LifeSciences, Inc. shareholders approved Election of five directors to serve until the 2023 Annual Meeting at the 2022-12-09 meeting.
“Proposal 1 . All of the five (5) nominees for director were elected to serve until the 2023 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, or until such director’s earlier resignation, removal or death. The result of the votes to elect the five (5) directors was as follows: Directors For Against Abstain Broker Non Vote David McWilliams 8,452,115 0 484,781 818,300 Snehal S. Patel 8,567,603 0 369,293 818,300 Eric Rothe 8,526,477 0 410,419 818,300 F. Joseph Daugherty, M.D. 8,532,215 0 404,681 818,300 Kenneth Hallock 8,561,615 0 375,281 818,300”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.